These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 20538790)

  • 1. Notch1 as a potential therapeutic target in cutaneous T-cell lymphoma.
    Kamstrup MR; Gjerdrum LM; Biskup E; Lauenborg BT; Ralfkiaer E; Woetmann A; Ødum N; Gniadecki R
    Blood; 2010 Oct; 116(14):2504-12. PubMed ID: 20538790
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NOTCH1 signaling as a therapeutic target in Sézary syndrome.
    van der Fits L; Qin Y; Out-Luiting JJ; Vermeer KG; Whittaker S; van Es JH; Tensen CP; Vermeer MH
    J Invest Dermatol; 2012 Dec; 132(12):2810-7. PubMed ID: 22718117
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low FAS/CD95 expression by CTCL correlates with reduced sensitivity to apoptosis that can be restored by FAS upregulation.
    Wu J; Nihal M; Siddiqui J; Vonderheid EC; Wood GS
    J Invest Dermatol; 2009 May; 129(5):1165-73. PubMed ID: 18923451
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proteasome inhibition as a novel mechanism of the proapoptotic activity of γ-secretase inhibitor I in cutaneous T-cell lymphoma.
    Biskup E; Kamstrup MR; Manfé V; Gniadecki R
    Br J Dermatol; 2013 Mar; 168(3):504-12. PubMed ID: 23445313
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Roles of OX40 and OX40 Ligand in Mycosis Fungoides and Sézary Syndrome.
    Kawana Y; Suga H; Kamijo H; Miyagaki T; Sugaya M; Sato S
    Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830466
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD147-Cyclophilin a Interactions Promote Proliferation and Survival of Cutaneous T-Cell Lymphoma.
    Sakamoto M; Miyagaki T; Kamijo H; Oka T; Boki H; Takahashi-Shishido N; Suga H; Sugaya M; Sato S
    Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360654
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Down-regulating constitutive activation of the NF-kappaB canonical pathway overcomes the resistance of cutaneous T-cell lymphoma to apoptosis.
    Sors A; Jean-Louis F; Pellet C; Laroche L; Dubertret L; Courtois G; Bachelez H; Michel L
    Blood; 2006 Mar; 107(6):2354-63. PubMed ID: 16219794
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of constitutively activated nuclear factor-kappaB induces reactive oxygen species- and iron-dependent cell death in cutaneous T-cell lymphoma.
    Kiessling MK; Klemke CD; Kaminski MM; Galani IE; Krammer PH; Gülow K
    Cancer Res; 2009 Mar; 69(6):2365-74. PubMed ID: 19258503
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemotherapeutic treatment is associated with Notch1 induction in cutaneous T-cell lymphoma.
    Kamstrup MR; Biskup E; Manfè V; Savorani C; Liszewski W; Wirèn J; Specht L; Gniadecki R
    Leuk Lymphoma; 2017 Jan; 58(1):171-178. PubMed ID: 27181628
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome): part I. Diagnosis: clinical and histopathologic features and new molecular and biologic markers.
    Jawed SI; Myskowski PL; Horwitz S; Moskowitz A; Querfeld C
    J Am Acad Dermatol; 2014 Feb; 70(2):205.e1-16; quiz 221-2. PubMed ID: 24438969
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heterogeneity of T-cell receptor expression at transformation in mycosis fungoides/Sezary Syndrome (MF/SS).
    Jothishankar B; Venkataraman G; Goldberg RC; Abdulla F
    Ann Diagn Pathol; 2019 Dec; 43():151404. PubMed ID: 31629155
    [No Abstract]   [Full Text] [Related]  

  • 12. Absence of T(H)2 cytokine messenger RNA expression in CD30-negative primary cutaneous large T-cell lymphomas.
    Vermeer MH; Tensen CP; van der Stoop PM; van Oostveen HW; Lund M; Scheper RJ; Willemze R
    Arch Dermatol; 2001 Jul; 137(7):901-5. PubMed ID: 11453809
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Upregulation of inhibitory signaling receptor programmed death marker-1 (PD-1) in disease evolution from cutaneous lymphoid dyscrasias to mycosis fungoides and Sezary's syndrome.
    Nguyen GH; Olson LC; Magro CM
    Ann Diagn Pathol; 2017 Jun; 28():54-59. PubMed ID: 28648940
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deciphering Tumor Cell Evolution in Cutaneous T-Cell Lymphomas: Distinct Differentiation Trajectories in Mycosis Fungoides and Sézary Syndrome.
    Jiang TT; Cao S; Kruglov O; Virmani A; Geskin LJ; Falo LD; Akilov OE
    J Invest Dermatol; 2024 May; 144(5):1088-1098. PubMed ID: 38036289
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Normal and cancer fibroblasts differentially regulate TWIST1, TOX and cytokine gene expression in cutaneous T-cell lymphoma.
    Mehdi SJ; Moerman-Herzog A; Wong HK
    BMC Cancer; 2021 May; 21(1):492. PubMed ID: 33941102
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor microenvironment in mycosis fungoides and Sézary syndrome.
    Rubio Gonzalez B; Zain J; Rosen ST; Querfeld C
    Curr Opin Oncol; 2016 Jan; 28(1):88-96. PubMed ID: 26632770
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The expression of cell adhesion molecule 1 and its splicing variants in Sézary cells and cell lines from cutaneous T-cell lymphoma.
    Yamaguchi M; Morizane S; Hamada T; Miyake T; Sugaya M; Iwata H; Fujii K; Haramoto-Shiratsuki R; Nakagawa Y; Miura M; Ohshima K; Morishita K; Takahashi T; Imada M; Okada K; Uehara J; Sowa-Osako J; Iwatsuki K
    J Dermatol; 2019 Nov; 46(11):967-977. PubMed ID: 31515833
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of IL-32 in cutaneous T-cell lymphoma.
    Suga H; Sugaya M; Miyagaki T; Kawaguchi M; Fujita H; Asano Y; Tada Y; Kadono T; Sato S
    J Invest Dermatol; 2014 May; 134(5):1428-1435. PubMed ID: 24226419
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Single-Cell RNA Sequencing Unveils the Clonal and Transcriptional Landscape of Cutaneous T-Cell Lymphomas.
    Gaydosik AM; Stonesifer CJ; Khaleel AE; Geskin LJ; Fuschiotti P
    Clin Cancer Res; 2022 Jun; 28(12):2610-2622. PubMed ID: 35421230
    [TBL] [Abstract][Full Text] [Related]  

  • 20. T-cell lymphoma cell lines (HUT102 and HUT78) established at the National Cancer Institute: history and importance to understanding the biology, clinical features, and therapy of cutaneous T-cell lymphomas (CTCL) and adult T-cell leukemia-lymphomas (ATLL).
    Bunn PA; Foss FM
    J Cell Biochem Suppl; 1996; 24():12-23. PubMed ID: 8806090
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.